Tamsulix T-Mepha retard Retardtabletten

Country: Switzerland

Language: Italian

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

tamsulosinum

Available from:

Mepha Pharma AG

ATC code:

G04CA02

INN (International Name):

tamsulosinum

Pharmaceutical form:

Retardtabletten

Composition:

tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, cellulosum microcristallinum, polyethyleni oxidum cum E 321, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto.

Class:

B

Therapeutic group:

Synthetika

Therapeutic area:

iperplasia prostatica Benigna

Authorization status:

zugelassen

Authorization date:

2011-03-10

Patient Information leaflet

•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato

Summary of Product characteristics

•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato